Vanishing bile duct syndrome temporally associated with ibuprofen use

American Journal of Gastroenterology

Volumn 91, Issue 8, 1996, Pages 1626-1630

  Alam, Imtiaz ^a   Ferrell, Linda D ^a   Bass, Nathan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CHLORPROMAZINE; COLESTYRAMINE; CYPROHEPTADINE; FLUCLOXACILLIN; HALOPERIDOL; IBUPROFEN; MEVINOLIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOTHIAZINE DERIVATIVE; PRASTERONE; TESTOSTERONE; TIABENDAZOLE; TRICYCLIC ANTIDEPRESSANT AGENT; URSODEOXYCHOLIC ACID;

ABDOMINAL PAIN; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPY; CASE REPORT; CHOLESTASIS; HEADACHE; HUMAN; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER TOXICITY; MALAISE; MALE; NAUSEA; OBSTRUCTIVE JAUNDICE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; VANISHING BILE DUCT SYNDROME; VOMITING; XANTHOMATOSIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BILE DUCTS, INTRAHEPATIC; BIOPSY; CHOLESTASIS, INTRAHEPATIC; HUMANS; IBUPROFEN; MALE; SYNDROME;

EID: 0029782822     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Garcia Rodriguez LA, Williams R, Derby LE, et al. Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med 1994;154:311-6.
2. Carson JL, Strom BL, Duff A, et al. Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease. Arch Intern Med 1993;153:1331-6.
3. Rabinovitz M, Van Thiel DH. Hepatoxicity of nonsteroidal anti-inflammatory drugs. Am J Gastroenterol 1992;87:1696-704.
4. Garcia Rodriguez LA, Gutthann SP, Walker AM, et al. The role of nonsteroidal anti-inflammatory drugs in acute liver injury. BMJ 1992; 305:865-8.
5. Tolman KG. Hepatotoxicity of antirheumatic drugs. J Rheumatol 1990;17 (suppl 22):6-11.
6. Prescott LF. Effects of non-narcotic analgesics on the liver. Drugs 1986;32(suppl4):129-47.
7. Lewis JH. Hepatic toxicity of nonsteroidal antiinflammatory drugs. Clin Pharm 1984;3:128-38.
8. Zimmerman HJ. Hepatotoxicity. Dis Mon 1993;39:675-783.
9. Insel PA. Analgesic-antipyretics and antiinflammatory agents: Drugs employed in the treatment of rheumatoid arthritis and gout. In: Goodman LS, Gilman A, Rall TW, et al, eds. Goodman and Gilman's the pharmacological basis of therapeutics, 8th ed. New York: Pergamon Press, 1990:665-8.
10. Johnson JH, Hershel J, Hunter JR, et al. A follow-up study of ibuprofen users. J Rheumatol 1985;12:549-52.
11. Friis H, Andreasen PB. Drug-induced hepatic injury: An analysis of 1100 cases reported to The Danish Committee on Adverse Drug Reactions between 1978 and 1987. J Intern Med 1992;232:133-8.
12. Stemlieb P, Robinson RM. Stevens-Johnson syndrome plus toxic hepatitis due to ibuprofen. N Y State J Med 1978;78:1239-43.
13. Stempel DA, Miller JJ III. Lymphopenia and hepatic toxicity with ibuprofen. J Pediatr 1977;90:657-8.
14. Brooks CD, Schlagel CA, Sekhar NC, et al. Tolerance and pharmacology of ibuprofen. Curr Ther Res 1973;15:180-90.
15. Bravo JF, Jacobson MP, Mertens BF. Fatty liver and pleural effusion with ibuprofen. Ann Intern Med 1977;87:200-1.
16. Woolf GM, Vierling JM. Disappearing intrahepatic bile ducts: The syndromes and their mechanisms. Semin Liver Dis 1993;13:261-75.
17. Farrell GC. Drug-induced cholestasis. In: Farrell GC, ed. Drug-induced liver disease, 1st ed. Churchill Livingstone, 1994:364-5.
18. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1987;316:521-8.
19. Wiesner RH. Current concepts in primary sclerosing cholangitis. Mayo Clin Proc 1994;69:969-82.
20. Sherlock S. The syndrome of disappearing intrahepatic bile ducts. Lancet 1987;2:493-6.
21. King PD, Blitzer BL. Drug-induced cholestasis: Pathogenesis and clinical features. Semin Liver Dis 1990;10:316-21.
22. Degott C, Feldman G, Larrey D, et al. Drug-induced prolonged cholestasis in adults: A histological semiquantitative study demonstrating progressive ductopenia. Hepatology 1992;15:244-51.
23. Ludwig J, Wiesner RH, LaRusso NF. Idiopathic adulthood ductopenia: A cause of chronic cholestatic liver disease and biliary cirrhosis. J Hepatol 1988;7:193-9.
24. Moradpour D, Altorfer J, Flury R, et al. Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis. Hepatology 1994;20:1437-41.
25. Walker CO, Combes B. Biliary cirrhosis induced by chlorpromazine. Gastroenterology 1966;51:631-40.
26. Read AE, Harrison CV, Sherlock S. Chronic chlorpromazine jaundice. Am J Med 1961;31:249-58.
27. Lok ASF, Ng IOL. Prochlorperazine-induced chronic cholestasis. J Hepatol 1988;6:369-73.
28. Dincsoy HP, Saelinger DA. Haloperidol-induced chronic cholestatic liver disease. Gastroenterology 1982;83:694-700.
29. Roy MA. Micronodular cirrhosis after thiabendazole. Dig Dis Sci 1989;34:938-41.
30. Manivel JC, Bloomer JR, Snover DC. Progressive bile duct injury after thiabendazole administration. Gastroenterology 1987;93:245-9.
31. Davies MH, Harrison RF, Elias E, et al. Antibiotic-associated acute vanishing bile duct syndrome: A pattern associated with severe, prolonged, intrahepatic cholestasis. J Hepatol 1994;20:112-6.
32. Eckstein RP, Dowsett JF, Lunzer MR. Flucloxacillin induced liver disease: Histopathological findings at biopsy and autopsy. Pathology 1993;25:223-8.
33. Smalley WE, Griffen MR, Fought RL, et al. Effect of a prior authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients. N Engl J Med 1995;332:1612-7.
34. Langman MJS. Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use. Gastroenterology 1989;96:640-6.
35. Tarazi EM, Harter JG, Zimmerman HJ, et al. Sulindac-associated hepatic injury: Analysis of 91 cases reported to the Food and Drug Administration. Gastroenterology 1993;104:569-74.
36. Hepps KS, Maliha GM, Estrada R, et al. Severe cholestatic jaundice associated with piroxicam. Gastroenterology 1991;101:1737-40.
37. Sonnenblick M, Abraham AH. Ibuprofen hypersensitivity in systemic lupus erythematous. BMJ 1978;1:619-20.
38. Lee CY, Finkler A. Acute intoxication due to ibuprofen overdose. Arch Pathol Lab Med 1986;110:747-9.
39. Altraif I, Lilly L, Wanless IR, et al. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole. Am J Gastroenterol 1994;89:1230-4.
40. de Galoscy C, Horsmans Y, Rahier J, et al. Vanishing bile duct syndrome occurring after carbamazepine: A second case report. J Clin Gastroenterol 1994;19:269-71.
41. Yamada S, Howe S, Scheuer PJ. Three-dimensional reconstruction of biliary pathways in primary biliary cirrhosis: A computer-assisted study. J Pathol 1987;152:317-23.
42. Alpini G, Lenzi R, Sarkozi, et al. Biliary physiology in rats with bile ductular cell hyperplasia: Evidence for a secretory function of proliferated bile ductules. J Clin Invest 1988;81:569-78.